Loading…
Hypophysiotropic Action of Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) in the Goldfish: Immunohistochemical Demonstration of PACAP in the Pituitary, PACAP Stimulation of Growth Hormone Release from Pituitary Cells, and Molecular Cloning of Pituitary Type I PACAP Receptor1
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a member of the glucagon/secretin peptide family, and its molecular structure is highly conserved in vertebrates. In this study, the functional role of PACAP in regulating GH release in the goldfish was investigated. Using immunohistochem...
Saved in:
Published in: | Endocrinology (Philadelphia) 1998-08, Vol.139 (8), p.3465-3479 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Pituitary adenylate cyclase-activating polypeptide (PACAP) is a member
of the glucagon/secretin peptide family, and its molecular structure is
highly conserved in vertebrates. In this study, the functional role of
PACAP in regulating GH release in the goldfish was investigated. Using
immunohistochemical staining, nerve fibers with PACAP immunoreactivity
were identified in the vicinity of goldfish somatotrophs, suggesting
that this neuropeptide may influence GH release in the goldfish. The
direct regulatory action of PACAP on GH secretion was demonstrated
in vitro in perifused goldfish pituitary cells. PACAPs
(0.01 nm to 1 μm) from different species,
including ovine PACAP27, ovine PACAP38, frog
PACAP38, zebra fish PACAP27, and zebra fish
PACAP38, were all effective in stimulating GH release with
ED50 values of 8.9 ± 3.5, 3.3 ± 1.6, 14.4±
3.5, 15.4 ± 4.1, and 1.4 ± 0.2 nm,
respectively. Similar concentrations of vasoactive intestinal
polypeptide (VIP), a peptide related to PACAP, was not effective in
this respect. In addition, the GH-releasing action of ovine
PACAP38 (10 nm) was inhibited by the PACAP
antagonist PACAP6–38 (10 μm), but not by the
VIP antagonist[
4-Cl-d-Phe6,Leu17]VIP (10μ
m). The pharmacology of these GH responses is consistent
with the mammalian type I PACAP receptors, suggesting that a similar
receptor subtype is present in the goldfish pituitary and mediates the
GH-releasing action of PACAP. To establish the structural identity of
this goldfish PACAP receptor, a complementary DNA (cDNA) clone sharing
a high degree of sequence homology with mammalian type I PACAP
receptors was isolated from a goldfish pituitary cDNA library. This
cDNA was 5.2 kb in size with a 1.4-kb open reading frame and encoded a
465-amino acid protein with the typical structure of a 7-transmembrane
domain-containing, G protein-coupled receptor. Functional expression of
this cDNA in COS-7 cells revealed that this fish type I PACAP receptor
could be activated by ovine PACAP27 and PACAP38
to increase cAMP synthesis with ED50 values of 2.4 ±
0.8 and 4.2 ± 1.2 nm, respectively. Other
structurally related peptides, including VIP (100 nm),
GH-releasing hormone (100 nm), glucagon (100
nm), secretin (100 nm), gastric inhibitory
polypeptide (100 nm), and PTH (100 nm), were
not effective in altering cAMP production. Using Northern blot and
RT-PCR, messenger RNA transcripts of this PACAP receptor were
identified in the brain, heart, and pituitary of the goldfish. These
results, tak |
---|---|
ISSN: | 0013-7227 1945-7170 |
DOI: | 10.1210/endo.139.8.6145 |